HeartWare Ventricular Assist System (HeartWare Controller) Product Usage: For use as a bridge...
FDA Device Recall #Z-1131-2015 — Class I — January 16, 2015
Recall Summary
| Recall Number | Z-1131-2015 |
| Classification | Class I — Serious risk |
| Date Initiated | January 16, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | HeartWare Inc |
| Location | Miami Lakes, FL |
| Product Type | Devices |
| Quantity | 4,845 |
Product Description
HeartWare Ventricular Assist System (HeartWare Controller) Product Usage: For use as a bridge-to-cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure. The HeartWare System is designed for in-hospital and out-of-hospital settings, including transportation via fix-wing aircraft or helicopter.
Reason for Recall
The affected clinical trial Controllers exhibit a higher susceptibility to ESD than newer commercial Controllers.
Distribution Pattern
Worldwide Distribution - US Nationwide in the states of: AL, AZ, CA, CO, FL, GA, IL, IN, KY, LA, MA, MD, MI, MN, MO, NC, NY, OH, OR, PA, TX, UT, VA, WA and District of Columbia and countries of: Canada, Poland, Australia, Austria, Italy, DE, New Zealand, South Africa, France, Switzerland, Germany, Brazil, UK, Belgium, Netherlands, Israel, Malaysia, Turkey, Greece, Japan, Singapore, Poland, Lithuania, Sweden, Norway, Finland, and India.
Lot / Code Information
Product Codes- US product: Model No.: 1400, 1401US; International product: Model No.: 1400, 1401XX ('XX' represents country designation) Serial No.: CON000001 through CON005472
Other Recalls from HeartWare Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1751-2015 | Class II | HeartWare Ventricular Assist System (HVAD) For ... | Apr 29, 2015 |
| Z-1726-2015 | Class I | HeartWare Ventricular Assist System (HVAD). Ca... | Apr 29, 2015 |
| Z-1698-2015 | Class I | HeartWare Ventricular Assist System (HVAD). Ca... | Apr 29, 2015 |
| Z-1731-2015 | Class I | HeartWare Ventricular Assist System (HVAD). ... | Apr 29, 2015 |
| Z-1917-2015 | Class II | HeartWare Ventricular Assist System (HVAD) For... | Apr 29, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.